title: Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease.
authors.forename: Dimitris
authors.initials: D
authors.lastname: Tousoulis
authors.forename: Pantelis
authors.initials: P
authors.lastname: Kourtellaris
authors.forename: Charalambos
authors.initials: C
authors.lastname: Antoniades
authors.forename: Carmen
authors.initials: C
authors.lastname: Vasiliadou
authors.forename: Nikos
authors.initials: N
authors.lastname: Papageorgiou
authors.forename: Costas
authors.initials: C
authors.lastname: Tentolouris
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Siasos
authors.forename: Elli
authors.initials: E
authors.lastname: Stefanadi
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D001783:Blood Flow Velocity; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D019040:E-Selectin / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005542:Forearm / Q000098:blood supply*; D006801:Humans; D006940:Hyperemia / Q000276:immunology; D007249:Inflammation; D018836:Inflammation Mediators / Q000097:blood*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D000077405:Irbesartan; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D020913:Perindopril / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
chemical_list: D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D019040:E-Selectin; D018836:Inflammation Mediators; D008055:Lipids; D013777:Tetrazoles; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; D000077405:Irbesartan; D020913:Perindopril